Dark
Light
System
Institutional Investment Manager
Broadfin Capital, LLC
Broadfin Capital, LLC (CIK: 0001511901) incorporated in Delaware, located at 300 Park Avenue, 25th Floor, New York, NY. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q4)
Portfolio Summary: 63 holdings with a total value of $900,720,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 HORIZON PHARMA PLC 5,959,819 96,430,000 10.71%
2 PROGENICS PHARMACEUTICALS IN 8,951,169 77,338,000 8.59%
3 RETROPHIN INC COM 3,269,271 61,887,000 6.87%
4 HERON THERAPEUTICS INC 3,899,587 51,085,000 5.67%
5 FLAMEL TECHNOLOGIES SA SPONSORED ADR 4,394,464 45,658,000 5.07%
6 ANTARES PHARMA INC 12,971,093 30,223,000 3.36%
7 ARATANA THERAPEUTICS INC COM 3,695,442 26,533,000 2.95%
8 LA JOLLA PHARMACEUTICAL CO 1,510,316 26,476,000 2.94%
9 ENDO INTL 1,560,038 25,694,000 2.85%
10 SOCIETAL CDMO INC 3,100,086 24,987,000 2.77%
11 ANGIODYNAMICS INC 1,471,152 24,818,000 2.76%
12 TEVA PHARMACEUTICAL INDS LTD 647,500 23,472,000 2.61%
13 ARALEZ PHARMACEUTICALS INC 4,791,590 21,131,000 2.35%
14 Lion Biotechnologies 2,638,259 18,336,000 2.04%
15 Aevi Genomic Medicine Inc 3,370,306 17,458,000 1.94%
16 NOVELION THERAPEUTICS INC 1,948,554 16,407,000 1.82%
17 MEDICINES CO 436,400 14,811,000 1.64%
18 VERACYTE INC 1,788,266 13,841,000 1.54%
19 DERMA SCIENCES INC COM PAR .01 2,562,104 13,323,000 1.48%
20 HORIZON PHARMA PLC 800,000 12,944,000 1.44% Call
21 TELIGENT INC NEW 1,931,711 12,769,000 1.42%
22 ACORDA THERAPEUTICS 644,153 12,110,000 1.34%
23 PARATEK PHARMACEUTICALS INC 786,134 12,106,000 1.34%
24 IGNYTA INC COM 2,256,546 11,960,000 1.33%
25 DURECT CORP 8,506,229 11,398,000 1.27%
26 ADVAXIS INC COM NEW 1,519,259 10,878,000 1.21%
27 BioDelivery Sciences International Inc 5,398,794 9,448,000 1.05%
28 ZOGENIX INC 766,412 9,312,000 1.03%
29 BARD C R INC 40,200 9,031,000 1.00%
30 EGALET CORP 10,000,000 8,923,000 0.99%
31 AMARIN CORP PLC 2,833,649 8,728,000 0.97%
32 SEASPINE HLDGS CORP COM 1,100,007 8,690,000 0.96%
33 ZIMMER BIOMET HLDGS INC 83,500 8,617,000 0.96%
34 CATALYST PHARMACEUTICALS INC 8,200,000 8,610,000 0.96%
35 ENDOLOGIX INC 1,500,000 8,580,000 0.95%
36 CORIUM INTERNATIONAL INC 1,919,721 7,794,000 0.87%
37 Strongbridge Biopharma plc 2,894,581 6,947,000 0.77%
38 IDERA PHARMACEUTICALS INC 4,427,745 6,642,000 0.74%
39 CIDARA THERAPEUTICS INC 562,875 5,854,000 0.65%
40 ADMA BIOLOGICS, INC. 1,113,293 5,700,000 0.63%
41 MEDTRONIC PLC 75,000 5,342,000 0.59%
42 PACIRA BIOSCIENCES INC 150,680 4,867,000 0.54%
43 GLAUKOS CORP 141,300 4,847,000 0.54%
44 PACIRA BIOSCIENCES INC 150,000 4,845,000 0.54% Call
45 SCYNEXIS INC 1,477,273 4,713,000 0.52%
46 ALCOBRA LTD 2,057,106 4,320,000 0.48%
47 AVIRAGEN THERAPEUTICS INC 3,486,711 4,289,000 0.48%
48 Egalet Corp 556,233 4,255,000 0.47%
49 NEXVET BIOPHARMA PUB LTD CO 1,127,200 4,205,000 0.47%
50 MIRATI THERAPEUTICS INC COM 826,001 3,924,000 0.44%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-17-001744, filed 2017.02.14).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.